Patent: 7,829,665

✉ Email this page to a colleague

« Back to Dashboard

▶ Start for $1
Remove trial restrictions

Summary for Patent: 7,829,665

Title:	Macrocyclic inhibitors of hepatitis C virus replication
Abstract:	The embodiments provide compounds of the general Formulae I through general Formula VIII, as well as compositions, including pharmaceutical compositions, comprising a subject compound. The embodiments further provide treatment methods, including methods of treating a hepatitis C virus infection and methods of treating liver fibrosis, the methods generally involving administering to an individual in need thereof an effective amount of a subject compound or composition.
Inventor(s):	Blatt; Lawrence M. (Brisbane, CA), Seiwert; Scott D. (Pacifica, CA), Andrews; Steven W. (Longmont, CO), Martin; Pierre (Rheinfelden, CH), Schumacher; Andreas (Efringen-Kirchen, DE), Barnett; Bradley (Northglenn, CO), Eary; C. Todd (Longmont, CO), Kaus; Robert (Longmont, CO), Kercher; Timothy (Boulder, CO), Liu; Weidong (Superior, CO), Lyon; Michael (Superior, CO), Nichols; Paul (Firestone, CO), Wang; Bin (Longmont, CO), Sammakia; Tarek (Boulder, CO), Kennedy; April (Denver, CO), Jiang; Yutong (Longmont, CO)
Assignee:	InterMune, Inc. (Brisbane, CA)
Application Number:	11/491,126
Patent Claims:	see list of patent claims

Details for Patent 7,829,665

Glossary

Subscribe to access the full database, or Try a Trial
Applicant	Tradename	Biologic Ingredient	Dosage Form	BLA	Approval Date	Patent No.	Expiredate
Kadmon Pharmaceuticals Llc	INFERGEN	interferon alfacon-1	Injection	103663	10/06/1997	See Plans and Pricing	2025-07-25
Janssen Biotech, Inc.	REMICADE	infliximab	For Injection	103772	08/24/1998	See Plans and Pricing	2025-07-25
Immunex Corporation	ENBREL	etanercept	For Injection	103795	11/02/1998	See Plans and Pricing	2025-07-25
>Applicant	>Tradename	>Biologic Ingredient	>Dosage Form	>BLA	>Approval Date	>Patent No.	>Expiredate

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.